期刊文献+

成纤维细胞激活蛋白和转化生长因子-β1在小鼠肝纤维化组织中的表达及相关性 被引量:3

Expression of FAP and its relationship with TGF-β1 in mouse hepatic fibrosis
下载PDF
导出
摘要 目的探讨成纤维细胞激活蛋白(FAP)、α-SMA和TGF-β1在小鼠肝纤维化组织中的表达和三者之间的关系。方法建立四氯化碳诱导的小鼠实验性肝纤维化模型,应用免疫组织化学技术检测小鼠肝纤维化组织中FAP、α-SMA和TGF-β1的表达。结果FAP、α-SMA和TGF-β1与小鼠肝纤维化程度呈正相关(rs分别为0.753,0.762,0.834,P<0.0001);且FAP与α-SMA、FAP与TGF-β1的表达均呈正相关(rs为0.825和0.814,P<0.0001)。结论FAP可作为判定肝纤维化程度的指标之一,且可能与TGF-β1共同促进肝纤维化进展。 Objective To investigate the expression of fibroblast activation protein (FAP),α-SMA and TGF-β1 in mouse hepatic fibrosis and relationship among them. Methods Experimental liver fibrosis model was induced with carbon tetrachloride.The expressions of FAP,α-SMA and TGF-β1 were detected with immunohistochemical technique in mouse hepatic fibrosis tissue. Results The immunoreactivity of FAP,α-SMA and TGF-β1 was positively correlated with the degree of hepatic fibrosis (rs =0.753,0.762,0.834,P〈0.000 1). Moreover,the expression of FAP had a positive correlation with α-SMA and TGF-β1 in hepatic fibrosis tissue respectively (rs=0.825 and 0.814,P〈0.000 1). Conclusion FAP may act as a useful marker to evaluate the degree of hepatic fibrosis and promote the progression of hepatic fibrosis together with TGF-β1.
出处 《肝脏》 2009年第6期454-457,共4页 Chinese Hepatology
基金 黑龙江省政府博士后科研启动基金(LRB07-144)
关键词 成纤维细胞激活蛋白 肝纤维化 肌成纤维细胞 转化生长因子-Β1 小鼠 Fibroblast activation protein Hepatic fibrosis Myofibroblast Transforming growth factor -β1 Mouse
  • 相关文献

参考文献10

  • 1靳占峰.成纤维细胞激活蛋白与肿瘤[J].国外医学(遗传学分册),2003,26(2):76-79. 被引量:15
  • 2Wang XM, Yao TW, Nadvi NA, et al. Fibrobtast activation protein and chronic liver disease. Frost Biosci, 2008, 13:3168-31811.
  • 3Gressner A M, Weiskirchen R . Modern pathogenetic concepls of liver fibrosis suggest stellate cells and TGF beta as major players and therapeutic targets. J Cell Mol Med,2006,10:76-99.
  • 4Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hapat, 1996,3:277-283.
  • 5Schmitt Graff A,Kruger S,Bochard F, et al. Modulation of alpha smoolh muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers . Am J Pathol, 1991,138: 1233-1242.
  • 6Cassiman D, Roskams T. Beauty is in the eye of the beholder: Emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol, 2002,37:527-535.
  • 7Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology, 1999,29:1768-1778.
  • 8Rettig WJ, Garin-Chesa P, Healey JH, et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res, 1993,53:3327-3335.
  • 9Rettig WJ, Su SL, Fortunato SR, et al. Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer, 1994,58:385-392.
  • 10Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int, 2006, 26:8-22.

二级参考文献10

  • 1Tanswell P et al. British Journal of Clinical Pharmacology . 2001
  • 2Niedermeyer J et al. European Journal of Biochemistry . 1998
  • 3Niedermeyer J et al. International Journal of Cancer . 1997
  • 4Cheng JD et al. Cancer Research . 2002
  • 5Ariga N et al. International Journal of Cancer . 2001
  • 6Rettig WJ et al. Proceedings of the National Academy of Sciences of the United States of America . 1988
  • 7Garin-Chesa P et al. Proceedings of the National Academy of Sciences of the United States of America . 1990
  • 8Park JE et al. Journal of Biological Chemistry . 1999
  • 9Rettig WJ et al. International Journal of Cancer . 1994
  • 10Rettig WJ et al. Cancer Research . 1993

共引文献14

同被引文献26

  • 1金树根,王灵台,任家潍,陈建杰,夏炎兴.二甲基亚硝胺致大鼠肝纤维化的造模研究[J].中西医结合肝病杂志,1994,4(1):28-30. 被引量:29
  • 2Christiansen V J, Jackson KW, Lee KN, el al. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types Ⅰ , Ⅲ, and Ⅳ [J]. Arch Biochem Biophys, 2007, 457(2) : 177-186.
  • 3Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis [J]. J Viral Hapat, 1996, 3(6): 277-283.
  • 4Schmitt-Graff A, Kruger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers [J]. Am J Pathol, 1991, 138(5): 1233-1242.
  • 5Wang XM, Yao TW, Nadvi NA, et al. Fibroblast activation protein and chronic liver disease [J]. Front Biosci, 2008, 13: 3168-3180.
  • 6Pardo A, Selman M. MMP-I: the elder of the family [J]. lnt J Biochem Cell Biol, 2005, 37(2) : 283-288.
  • 7Hart YP. Matrix metalloproteinases, the pros and cons, in liver fibrosis [J].J Gastroenterol Hepatol, 2006, 21 ( 3 ) : S88-S91.
  • 8Murata K, Kamata Y, Nunakata H, el al. hnmunohistochemical study on liver fibrosis in biliary atresia[J], Hepatogastroenterology. 2008, 55(81): 179-183.
  • 9Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment [J] ? Am J Physiol Lung Cell Mol Physiol, 2000, 279(3): L562-L574.
  • 10Zuo F,Kaminaki N,Eugui E ,et al.Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans[J].Proc Natl Acad Sci U S A,2002.99(9):6292-6297.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部